Literature DB >> 28186438

A semiautomated microfluidic platform for real-time investigation of nanoparticles' cellular uptake and cancer cells' tracking.

Mariana R Carvalho1,2, F Raquel Maia1,2, Joana Silva-Correia1,2, Bruno M Costa2,3, Rui L Reis1,2, Joaquim M Oliveira1,2.   

Abstract

AIM: Develop a platform composed of labeled dendrimer nanoparticles (NPs) and a microfluidic device for real-time monitoring of cancer cells fate. MATERIALS &
METHODS: Carboxymethylchitosan/poly(amidoamine) dendrimer NPs were labeled with fluorescein-5(6)-isothiocyanate and characterized using different physicochemical techniques. After, HeLa, HCT-116 and U87MG were cultured in the presence of NPs, and cell viability and internalization efficiency in static (standard culture) and dynamic (microfluidic culture) conditions were investigated.
RESULTS: Cancer cells cultured with NPs in dynamic conditions were viable and presented higher internalization levels as compared with static 2D cultures.
CONCLUSION: This work demonstrated that the proposed microfluidic-based platform allows real-time monitoring, which upon more studies, namely, the assessment of an anticancer drug release effect could be used for cancer theranostics.

Entities:  

Keywords:  cell tracking; circulating tumor cells; microfluidics; nanoparticles; theranostics

Mesh:

Substances:

Year:  2017        PMID: 28186438     DOI: 10.2217/nnm-2016-0344

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  2 in total

Review 1.  Recent advances of controlled drug delivery using microfluidic platforms.

Authors:  Sharma T Sanjay; Wan Zhou; Maowei Dou; Hamed Tavakoli; Lei Ma; Feng Xu; XiuJun Li
Journal:  Adv Drug Deliv Rev       Date:  2017-09-15       Impact factor: 15.470

2.  Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine.

Authors:  M R Carvalho; D Barata; L M Teixeira; S Giselbrecht; R L Reis; J M Oliveira; R Truckenmüller; P Habibovic
Journal:  Sci Adv       Date:  2019-05-22       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.